Eugene L. Asahchop

Antiviral Drug Resistance and the Need for Development of New HIV-1 Reverse Transcriptase Inhibitors

Eugene L. Asahchop, Mark A. Wainberg, Richard D. Sloan et al. · Antimicrobial Agents and Chemotherapy · 2012 · 103 citations

Reverse Transcriptase Inhibitor, Immunology, Pharmacotherapy +16

Compensation by the E138K Mutation in HIV-1 Reverse Transcriptase for Deficits in Viral Replication Capacity and Enzyme Processivity Associated with the M184I/V Mutations

Hongtao Xu, Eugene L. Asahchop, Maureen Oliveira et al. · Journal of Virology · 2011 · 95 citations · Full text

Viral Replication, Engineering, Viral Polymerase Structure +23

MicroRNAs upregulated during HIV infection target peroxisome biogenesis factors: Implications for virus biology, disease mechanisms and neuropathology

Zaikun Xu, Eugene L. Asahchop, William G. Branton et al. · PLoS Pathogens · 2017 · 82 citations · Full text

Immunology, Disease Mechanisms, Social Sciences +22

Insulin Treatment Prevents Neuroinflammation and Neuronal Injury with Restored Neurobehavioral Function in Models of HIV/AIDS Neurodegeneration

Manmeet K. Mamik, Eugene L. Asahchop, Wing Fuk Chan et al. · Journal of Neuroscience · 2016 · 79 citations · Full text

Effect of Mutations at Position E138 in HIV-1 Reverse Transcriptase and Their Interactions with the M184I Mutation on Defining Patterns of Resistance to Nonnucleoside Reverse Transcriptase Inhibitors Rilpivirine and Etravirine

Hongtao Xu, Susan P. Colby-Germinario, Eugene L. Asahchop et al. · Antimicrobial Agents and Chemotherapy · 2013 · 69 citations · Full text

Drug Susceptibility, Medicine, M184i Mutation +13